Clinical trial
Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
NCT01328769 is registered in ClinicalTrials.gov with Paul N. Hopkins as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)
- Lead sponsor
- Paul N. Hopkins
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- January 31, 2014
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.